Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity (Q40838217)

24 September 2017

title

Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity (English)

1 reference

24 September 2017

Sudhir Landge

1

1 reference

24 September 2017

Vasanthi Ramachandran

2

1 reference

24 September 2017

Anupriya Kumar

3

1 reference

24 September 2017

João Neres

4

1 reference

24 September 2017

Kannan Murugan

5

1 reference

24 September 2017

Claire Sadler

6

1 reference

24 September 2017

Mick D Fellows

7

1 reference

24 September 2017

Vaishali Humnabadkar

8

1 reference

24 September 2017

Prakash Vachaspati

9

1 reference

24 September 2017

Anandkumar Raichurkar

10

1 reference

24 September 2017

Sreevalli Sharma

11

1 reference

24 September 2017

Sudha Ravishankar

12

1 reference

24 September 2017

Supreeth Guptha

13

1 reference

24 September 2017

Vasan K Sambandamurthy

14

1 reference

24 September 2017

Tanjore S Balganesh

15

1 reference

24 September 2017

Bheemarao G Ugarkar

16

1 reference

24 September 2017

V Balasubramanian

17

1 reference

24 September 2017

Balachandra S Bandodkar

18

1 reference

24 September 2017

Manoranjan Panda

19

1 reference

24 September 2017

publication date

11 January 2016

1 reference

24 September 2017

1 reference

24 September 2017

volume

11

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

331-339

1 reference

Mutagenicity of nitroaromatic compounds

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

A Prodrug Approach to Improve the Physico-Chemical Properties and Decrease the Genotoxicity of Nitro Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Lessons from seven decades of antituberculosis drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Advances in the development of new tuberculosis drugs and treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Revised methods for the Salmonella mutagenicity test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

The Ames Salmonella/microsome mutagenicity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

The influence of methyl substitution of the mutagenicity of nitronaphthalenes and nitrobiphenyls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

From mutagenic to non-mutagenic nitroarenes: effect of bulky alkyl substituents on the mutagenic activity of 4-nitrobiphenyl in Salmonella typhimurium. Part I. Substituents ortho to the nitro group and in 2'-position

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Reaction energies computed with density functional theory correspond with a whole organism effect; modelling the Ames test for mutagenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Explanation for Main Features of Structure–Genotoxicity Relationships of Aromatic Amines by Theoretical Studies of Their Activation Pathways in CYP1A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Phasercrystallographic software

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Coot: model-building tools for molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Refinement of macromolecular structures by the maximum-likelihood method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Overview of the CCP4 suite and current developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Stereochemistry of polypeptide chain configurations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Presenting your structures: the CCP4mg molecular-graphics software

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

Rationally designing safer anilines: the challenging case of 4-aminobiphenyls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

7 January 2021

Generation of naphthoquinone radical anions by electrospray ionization: solution, gas-phase, and computational chemistry studies

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

7 January 2021

Stabilizers cause instability

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

7 January 2021

Switching Pathways: Room-Temperature Neutral Solvolysis and Substitution of Amides

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

7 January 2021

Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

7 January 2021

Ionization Potential, Electron Affinity, Electronegativity, Hardness, and Electron Excitation Energy: Molecular Properties from Density Functional Theory Orbital Energies

1 reference

https://api.crossref.org/works/10.1002/CMDC.201500462

7 January 2021

Identifiers

DOI

10.1002/CMDC.201500462

1 reference

release_kyi7d44y7raf7kz3mecwujobe4

24 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kyi7d44y7raf7kz3mecwujobe4

24 November 2022

mapped directly with Wikidata item

1 reference